Riken Vitamin Co., Ltd. (JP:4526)
:4526
Want to see JP:4526 full AI Analyst Report?
4526 Stock Chart & Stats
¥2967.00
-¥30.00(-1.23%)
At close: 4:00 PM EST
¥2967.00
-¥30.00(-1.23%)
Day’s Range― - ―
52-Week Range¥2,477.00 - ¥3,285.00
Previous CloseN/A
Volume73.90K
Average Volume (3M)91.61K
Market Cap
¥63.51B
Enterprise Value¥68.56B
Total Cash (Recent Filing)¥20.05B
Total Debt (Recent Filing)¥10.13B
Price to Earnings (P/E)12.1
Beta0.53
Next Earnings
Aug 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.63%
Share Statistics
EPS (TTM)293.59
Shares Outstanding30,705,100
10 Day Avg. Volume57,120
30 Day Avg. Volume91,606
Financial Highlights & Ratios
PEG Ratio-0.52
Price to Book (P/B)1.02
Price to Sales (P/S)0.88
P/FCF Ratio91.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)213.9
Revenue Forecast (FY)¥96.20B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage and a large equity base give the company durable financial flexibility. With debt-to-equity near 0.09, Riken Vitamin can fund R&D, absorb demand shocks, maintain dividends or invest in strategic acquisitions without pressuring liquidity over the next several quarters.
Multi-year Profit RecoveryA sustained recovery in profitability since 2021, with ROE in the high single digits (~8.4% in 2026), indicates resilient operating improvements. That trend supports durable earnings power, improves stakeholder confidence, and underpins reinvestment in product development and commercial efforts.
Steady Revenue GrowthConsistent top-line expansion provides a stable platform for margin recovery and scale benefits. Steady revenue—across ingredient sales to manufacturers and consumer packaged products—supports predictable production planning, long-term customer relationships, and returns on R&D investments.
Bears Say
Sharp FCF DeclineA large fall in free cash flow reduces the firm's ability to self-fund capex, pay dividends, or pursue bolt-on M&A without altering financing. If persistent, this weaker cash generation erodes financial resilience and increases reliance on internal working-capital management or external funding.
Weakened Cash ConversionDeclining conversion of accounting profits into free cash signals higher reinvestment needs or working-capital strain. Persistently low conversion reduces available discretionary cash, constrains balance-sheet optionality, and raises the bar for sustained shareholder returns or debt paydown.
Margin NormalizationCompression from prior peak margins indicates pressure on pricing, input costs, or product mix. If structural, lower margins will cap long-term cash flow and returns, limiting reinvestment and reducing the company's buffer against competition or commodity volatility over the next several quarters.
Riken Vitamin Co., Ltd. News
4526 FAQ
What was Riken Vitamin Co., Ltd.’s price range in the past 12 months?
Riken Vitamin Co., Ltd. lowest stock price was ¥2477.00 and its highest was ¥3285.00 in the past 12 months.
What is Riken Vitamin Co., Ltd.’s market cap?
Riken Vitamin Co., Ltd.’s market cap is ¥63.51B.
When is Riken Vitamin Co., Ltd.’s upcoming earnings report date?
Riken Vitamin Co., Ltd.’s upcoming earnings report date is Aug 12, 2026 which is in 83 days.
How were Riken Vitamin Co., Ltd.’s earnings last quarter?
Riken Vitamin Co., Ltd. released its earnings results on May 13, 2026. The company reported ¥37.44 earnings per share for the quarter, beating the consensus estimate of N/A by ¥37.44.
Is Riken Vitamin Co., Ltd. overvalued?
According to Wall Street analysts Riken Vitamin Co., Ltd.’s price is currently Overvalued.
Does Riken Vitamin Co., Ltd. pay dividends?
Riken Vitamin Co., Ltd. pays a Semiannually dividend of ¥55 which represents an annual dividend yield of 3.63%. See more information on Riken Vitamin Co., Ltd. dividends here
What is Riken Vitamin Co., Ltd.’s EPS estimate?
Riken Vitamin Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Riken Vitamin Co., Ltd. have?
Riken Vitamin Co., Ltd. has 30,705,100 shares outstanding.
What happened to Riken Vitamin Co., Ltd.’s price movement after its last earnings report?
Riken Vitamin Co., Ltd. reported an EPS of ¥37.44 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.914%.
Which hedge fund is a major shareholder of Riken Vitamin Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4526
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Riken Vitamin Co., Ltd.
Riken Vitamin Co., Ltd. engages in the food ingredient, food application, health care, and chemical businesses in Japan. It offers food emulsifies for use in bread, cake, whipped topping, coffee cream, margarine, tofu, jam, marmalade, ice cream, cocoa, chocolate, noodle, and mashed potato applications; and distilled diglycerine ester, a substance that diglycerine reacts with fatty acids. The company also provides natural tocopherol for retarding oxidation to keep food products fresh; natural food colors; flavors for seasoning, sea food, chicken, and beef products; wakame seaweed that is used in wakame soup, seafood salads, instant noodles, and cup noodle ingredients; and stabilizers and emulsifiers system for frozen desserts and dairy products, as well as bakery emulsifiers and bread improvers, and cake improving agents and emulsifiers. In addition, it offers chemical improving agents, such as glycerol, polyglycerol, sorbitan, propylene glycol, and specialty esters, as well as other agents; and vitamins. The company was formerly known as Riken Vitamin Oil Co., Ltd. and changed its name to Riken Vitamin Co., Ltd. in 1980. Riken Vitamin Co., Ltd. was founded in 1917 and is headquartered in Tokyo, Japan.
Technical Analysis
Ajinomoto Co
―
Morinaga Milk Industry Co., Ltd.
―
Fuji Oil Holdings, Inc.
―
AFC-HD AMS Life Science Co., Ltd.
―
Lacto Japan Co., Ltd.
―
Options Prices
Currently, No data available
---